New Combo Drug Approved for Alzheimer's Dementia Monthly Prescribing Reference Actavis and Adamas announced that the Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Namzaric (memantine HCl extended-release and donepezil HCl) capsules for the treatment of moderate to severe Alzheimer's … and more »

Alzheimer's, in the Open New York Times Frank Bruni would have been heartened to read the many articles reporting the decline in dementia rates (including Alzheimer's) in developed countries. Based on estimates from the Framingham study, a 60-year-old in the United States today has about 44 … Helping someone in the early stages Of Alzheimer's DiseaseLincoln Journal Star Alzheimer's Association to host “Living with Alzheimer's disease” seriesThe Polk Fish Wrap all 3 news articles »

The Dementia that is NOT Alzheimer's Disease EGP News Dementia experts are more experienced at differentiating between dementia types. Alzheimer's disease affects cognitive function, including making new experiences into memories. The disorder in LBD affects different aspects of cognition, such as problem …

Dr. Shayesteh: Ways to slow Alzheimer's Disease WKBN.com Dr. Shayesteh said there are ways to slow down and even reverse the disease as well as dementia through diet and exercise. He said new research using human subjects shows nutritional and lifestyle changes can prevent or slow some of the early signs of …

Alzheimer's Combo Treatment OKd by FDA Newsmax Health The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis and Adamas Pharmaceuticals. Adamas shares were up nearly 17 percent at $17.10 in premarket trading. The drug, Namzaric is …

Pharmaceutical Business Review

UPDATE 1-Actavis, Adamas win FDA approval for Alzheimer's drug Reuters (Adds details, background, share). Dec 24 (Reuters) – The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis Plc and Adamas Pharmaceuticals Inc. Adamas shares were up nearly 17 … Actavis, Adamas Pharma Win FDA Approval For Alzheimer's Drug NamzaricNasdaq Actavis Alzheimers Drug Approved; Bystolic Gets CRLZacks.com Actavis, Adamas win FDA approval for Alzheimer's drugWTAQ Drug Discovery & Development all 66 news articles »

Pharmaceutical Business Review

Actavis, Adamas win FDA approval for Alzheimer's drug Reuters (Reuters) – The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis Plc and Adamas Pharmaceuticals Inc. Adamas shares were up nearly 17 percent at $17.10 in premarket trading. Actavis, Adamas Pharma Win FDA Approval For Alzheimer's Drug NamzaricNasdaq all 66 news articles »

PsychCentral.com (blog)

Recognizing Alzheimer's Cousin: Lewy Body Dementia PsychCentral.com (blog) A new symptom comparison chart has just been issued by the Lewy Body Dementia Association (LBDA) that helps people recognize the differences between Lewy body dementia (LBD) and Alzheimer's disease. LBD is a complex, challenging, and …

Jakarta Post

Mother's Day: Collaborative endeavors needed to empower dementia-sufferers Jakarta Post Disorientation and memory loss are among the signs that a person has dementia or Alzheimer's. Irritation and forgetfulness are common reactions to people with Alzheimer's. DY Suharya, whose mother was diagnosed with Alzheimer's, initially reacted in … New Developments in Alzheimer's Disease TreatmentPharmacy Times all 3 news articles »

expressandstar.com

Black Country couple share dementia story on national TV expressandstar.com Earlier this year, the city council's cabinet members took part in an Alzheimer's awareness sessions led by the society. It called for the development of a number of dementia-friendly communities around the country, and over the past two years health …